Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shugan Lidan Formula is a Traditional Chinese Medicine (TCM) herbal composition being investigated for its potential to prevent the recurrence of common bile duct stones (choledocholithiasis) following surgical or endoscopic removal. Developed and studied by researchers at The Second Hospital of Shandong University, the formula is designed to "soothe the liver and benefit the gallbladder," a TCM therapeutic principle aimed at improving bile secretion and flow (choleretic effect) and reducing biliary inflammation. By modulating the lithogenicity of bile and enhancing gallbladder motility, the formula seeks to address the underlying biliary stasis and metabolic imbalances that lead to stone formation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shugan lidan formula.